CTN-0108: Transcranial magnetic stimulation for the treatment of stimulant use disorders.
In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder. Dr. Brady, co-Principal Investigator for CTN-0108, presented the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.
Related protocols: CTN-0108
Categories:
Cocaine, Methamphetamine, Stimulant use, Transcranial Magnetic Stimulation (TMS)
Authors :
Brady, Kathleen T.
Source :
Webinar for the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network, June 2025